Laboratory Investigation
United States and Canadian Academy of Pathology The United States and Canadian Academy of Pathology
LWW Lippincott Williams and Wilkins
publishes Laboratory Investigation
--
                                      View Future Titles
Through Mar 2001
       Archives
Aug 1965 - Feb 2001
       Search Articles
Aug 1965 - Feb 2001
       Browse by Subject
Aug 1965 - Feb 2001
                      
Instructions to authors

Subscriptions

About the journal
   
  Involvement of Growth-Related Protein in Lipopolysaccharide-Induced Rabbit Arthritis: Cooperation between Growth-Related Protein and IL-8, and Interrelated Regulation among TNF[alpha], IL-1, IL-1 Receptor Antagonist, IL-8, and Growth-Related Protein
Editorial board

Email alerts

'Net Tips

Help

Feedback

Guestbook








  Akihiro Matsukawa, Teizo Yoshimura, Kazunori Fujiwara, Takako Maeda, Susumu Ohkawara, and Masaru Yoshinaga
   
  Department of Pathology (AM, KF, TM, SO, MY), Kumamoto University School of Medicine, Kumamoto, Japan; and Immunopathology Section (TY), Laboratory of Immunology, National Cancer Institute, Frederick Cancer Research and Development Center, Frederick, Maryland
   
  We investigated the functional role of a CXC chemokine, growth-related protein (GRO), in the recruitment of neutrophils in lipopolysaccharide (LPS)-induced rabbit arthritis. The amounts of GRO in the synovial fluids (SF) reached the first peak (major) at 2 hours and the second peak (minor) at 9 hours after injection of LPS into the knee joints. Administration of anti-GRO mouse monoclonal antibody inhibited 54% of the peak leukocyte accumulation at 9 hours (neutrophils greater than 95%), which was similar to the inhibition by anti-IL-8 IgG (48%). Co-administration of these inhibitors increased the inhibition up to 70% at 9 hours and also inhibited 65% of the initial phase of leukocyte infiltration at 2 hours (neutrophils greater than 99%), which was not affected by a single administration of each inhibitor. The amounts of GRO in SF at 2 hours were not altered by either anti-TNF[alpha] mAb or anti-IL-8 IgG, but reduced by rabbit recombinant IL-1 receptor antagonist (rrIL-1Ra) by 39%. The inhibition by rrIL-1Ra was augmented further to 59% with coadministered anti-TNF[alpha] mAb. In contrast, the amounts of GRO at 9 hours were reduced by rrIL-1Ra by 67%. There was no additional reduction in the amounts of GRO at 9 hours by either combination of rrIL-1Ra with anti-TNF[alpha] mAb or anti-IL-8 IgG. Administration of anti-GRO mAb did not alter TNF[alpha] or IL-8 contents in SF at their peak (2 hours), but reduced the amounts of IL-1[beta] at 6 hours and IL-1Ra at 9 hours by 42% and 49%, respectively. These results provide evidence for the following: (a) GRO as well as IL-8 are important mediators involved in the recruitment of neutrophils both in the early and the late phase of LPS-induced arthritis, (b) IL-1 produced in the early phase stimulates GRO production, (c) GRO plays a role in the later induction of IL-1[beta] and IL-1Ra, and (d) induction of GRO is not regulated by IL-8. (Lab Invest, 79:591-600).